Incidence of postoperative residual neuromuscular blockade in the postanaesthesia care unit: An observational multicentre study in Portugal

European Journal of Anaesthesiology

Volumn 30, Issue 5, 2013, Pages 243-249

  Esteves, Simão ^a   Martins, Mafalda ^b   Barros, Filinto ^a   Barros, Fernanda ^c   Canas, Manuela ^d   Vitor, Paula ^e   Seabra, Manuel ^f   Castro, Maria M ^g   Bastardo, Isabel ^b  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^b CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^c HOSPITAL DE SÃO JOÃO   (Portugal)

^d CENTRO HOSPITALAR DE VILA NOVA DE GAIA ESPINHO   (Portugal)

^e HOSPITAL DE SANTA MARIA   (Portugal)

^f HOSPITAL PEDRO HISPANO   (Portugal)

^g Hospital Prof Doutor Fernando Fonseca   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM BESILATE; ATROPINE; CEFAZOLIN; CEFOTAXIME; CISATRACURIUM; DEXAMETHASONE; DROPERIDOL; EPHEDRINE; FENTANYL; HYDROCORTISONE; KETOROLAC; METOCLOPRAMIDE; MIDAZOLAM; MORPHINE; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; ONDANSETRON; PARACETAMOL; PARECOXIB; PROPOFOL; RANITIDINE; REMIFENTANIL; ROCURONIUM; ROPIVACAINE; SEVOFLURANE; SUGAMMADEX; TRAMADOL; VECURONIUM;

ABDOMINAL WALL; ABSENCE OF SIDE EFFECTS; ACCELEROMETRY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANESTHESIST; ARTICLE; CELLULITIS; CLINICAL ASSESSMENT; DYSPNEA; ELECTIVE SURGERY; ENDOCRINE DISEASE; FEMALE; GASTROINTESTINAL DISEASE; GENERAL ANESTHESIA; HEMOPERITONEUM; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HUMAN; IMMUNOPATHOLOGY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; METABOLIC DISORDER; MYOGRAPHY; NEUROMUSCULAR BLOCKING; OBSERVATIONAL STUDY; PARALYTIC ILEUS; PNEUMONIA; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; RECOVERY ROOM; REOPERATION; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; SEPTIC SHOCK; SKIN DISEASE; SURGICAL INFECTION; UROGENITAL TRACT DISEASE; ANESTHETIC RECOVERY; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; PORTUGAL; POSTOPERATIVE CARE; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANESTHESIA RECOVERY PERIOD; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; PORTUGAL; POSTOPERATIVE CARE;

EID: 84879109088     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32835dccd7     Document Type: Article

References (27)

1. Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg 2010; 111:120-128.
2. Berg H, Roed J, Viby-Mogensen J, et al. Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 1997; 41:1095-1103.
3. Murphy GS, Szokol JW, Marymont JH, et al. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 2008; 107:130-137.
4. Eriksson LI, Sato M, Severinghaus JW. Effect of a vecuronium-induced partial neuromuscular block on hypoxic ventilatory response. Anesthesiology 2003; 78:693-699.
5. Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology 2003; 98:1042-1048.
6. Murphy GS. Residual neuromuscular blockade: incidence, assessment and relevance in the postoperative period.Minerva Anestesiol 2006; 72:97- 109.
7. Eriksson LI. Residual neuromuscular blockade. Anaesthesist 2000; 49 (Suppl 1):S18-S19.
8. Claudius C, Garvey LH, Viby-Mogensen J. The undesirable effects of neuromuscular blocking drugs. Anaesthesia 2009; 64 (Suppl 1):10-21.
9. Baillard C, Clec'h C, Catineau J, et al. Postoperative residual neuromuscular block: a survey of management. Br J Anaesth 2005; 95:622-626.
10. Ali HH, Utting JE, Gray TC. Quantitative assessment of residual antidepolarizing block. II. Br J Anaesth 1971; 43:478-485.
11. Viby-Mogensen J. Postoperative residual curarization and evidence-based anaesthesia. Br J Anaesth 2000; 84:301-303.
12. Kopman AF. Undetected residual neuromuscular block has consequences. Anesthesiology 2008; 109:363-364.
13. Murphy GS, Szokol JW, Marymont JH, et al. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit. Anesthesiology 2008; 109:389-398.
14. Brull SJ, Murphy GS. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesth Analg 2010; 111:129-140.
15. Brull SJ, Naguib M, Miller RD. Residual neuromuscular block: rediscovering the obvious. Anesth Analg 2008; 107:11-14.
16. Kopman AF, Zank LM, Ng J, Neuman GG. Antagonism of cisatracurium and rocuronium block at a tactile train-of-four count of 2: should quantitative assessment of neuromuscular function be mandatory? Anesth Analg 2004; 98:102-106.
17. Yip PC, Hannam JA, Cameron AJD, Campbell D. Incidence of neuromuscular blockade in a postanaesthetic care unit. Anaesth Intensive Care 2010; 38:91-95.
18. Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis. Br J Anaesth 2007; 98:302-316.
19. Maybauer DM, Geldner G, Blobner M, et al. Incidence and duration of residual paralysis at the end of surgery after multiple administrations of cisatracurium and rocuronium. Anaesthesia 2007; 62:12-17.
20. Murphy GS, Szokol JW, Marymont JH, et al. Residual paralysis at the time of tracheal extubation. Anesth Analg 2005; 100:1840-1845.
21. Murphy GS, Szokol JW, Franklin M, et al. Postanesthesia care unit recovery times and neuromuscular blocking drugs: a prospective study of orthopedic surgical patients randomized to receive pancuronium or rocuronium. Anesth Analg 2004; 98:193-200.
22. Murphy GS, Szokol JW, Marymont JH, et al. Recovery of neuromuscular function after cardiac surgery: pancuronium versus rocuronium. Anesth Analg 2003; 96:1301-1307.
23. Cammu G, De Witte J, De Veylder J, et al. Postoperative residual paralysis in outpatients versus inpatients. Anesth Analg 2006; 102:426-429.
24. Cheng CR, Sessler DI, Apfel CC. Does neostigmine administration produce a clinically important increase in postoperative nausea and vomiting? Anesth Analg 2005; 101:1349-1355.
25. Tramèr MR, Fuchs-Buder T. Omitting antagonism of neuromuscular block: effect on postoperative nausea and vomiting and risk of residual paralysis. A systematic review. Br J Anaesth 1999; 82:379-386.
26. Lowry DW, Mirakhur RK, McCarthy GJ, et al. Neuromuscular effects of rocuronium during sevoflurane, isoflurane, and intravenous anesthesia. Anesth Analg 1998; 87:936-940.
27. Capron F, Alla F, Hottier C, et al. Can acceleromyography detect low levels of residual paralysis? A probability approach to detect a mechanomyographic train-of-four ratio of 0.9. Anesthesiology 2004; 100:1119-1124.